{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:24:18Z","timestamp":1793384658721,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s40644-018-0175-3","type":"journal-article","created":{"date-parts":[[2018,10,31]],"date-time":"2018-10-31T21:52:41Z","timestamp":1541022761000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["68Ga-PSMA PET\/CT in prostate cancer patients \u2013 patterns of disease, benign findings and pitfalls"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6057-778X","authenticated-orcid":false,"given":"Zohar","family":"Keidar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elinor","family":"Goshen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ora","family":"Israel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tima","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryna","family":"Morgulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Pirmisashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ben-Haim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,1]]},"reference":[{"key":"175_CR1","unstructured":"Society AC. Cancer Facts&Figures: American cancer Societ- Atlanta; 2017."},{"issue":"Suppl 5","key":"175_CR2","doi-asserted-by":"publisher","first-page":"v69","DOI":"10.1093\/annonc\/mdv222","volume":"26","author":"C Parker","year":"2015","unstructured":"Parker C, Gillessen S, Heidenreich A, Horwich A. Cancer of the prostate: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v69\u201377.","journal-title":"Ann Oncol"},{"issue":"5","key":"175_CR3","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1053\/hp.2000.6698","volume":"31","author":"L Bubendorf","year":"2000","unstructured":"Bubendorf L, Schopfer A, Wagner U, et al. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol. 2000;31(5):578\u201383.","journal-title":"Hum Pathol"},{"issue":"2","key":"175_CR4","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2214\/AJR.11.7533","volume":"199","author":"AH Vinjamoori","year":"2012","unstructured":"Vinjamoori AH, Jagannathan JP, Shinagare AB, et al. Atypical metastases from prostate cancer: 10-year experience at a single institution. AJR Am J Roentgenol. 2012;199(2):367\u201372.","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"175_CR5","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1097\/MNM.0000000000000566","volume":"37","author":"E Demirci","year":"2016","unstructured":"Demirci E, Sahin OE, Ocak M, Akovali B, Nematyazar J, Kabasakal L. Normal distribution pattern and physiological variants of 68Ga-PSMA-11 PET\/CT imaging. Nucl Med Commun. 2016;37(11):1169\u201379.","journal-title":"Nucl Med Commun"},{"issue":"4","key":"175_CR6","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00259-012-2298-2","volume":"40","author":"A Afshar-Oromieh","year":"2013","unstructured":"Afshar-Oromieh A, Malcher A, Eder M, et al. PET imaging with a [68Ga] gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. Eur J Nucl Med Mol Imaging. 2013;40(4):486\u201395.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"175_CR7","unstructured":"Fragomeni. PSMA-targeted Imaging: Beyond Prostate Cancer PET Center of Excellence Newsletter 2016;13(1)."},{"issue":"5","key":"175_CR8","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1007\/s00259-017-3922-y","volume":"45","author":"P Backhaus","year":"2018","unstructured":"Backhaus P, Noto B, Avramovic N, et al. Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives. Eur J Nucl Med Mol Imaging. 2018;45(5):860\u201377.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"175_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.2967\/jnumed.117.203570","volume":"59","author":"RA Salas Fragomeni","year":"2018","unstructured":"Salas Fragomeni RA, Amir T, Sheikhbahaei S, Harvey SC, Javadi MS, Solnes LB, et al. Imaging of nonprostate cancers using PSMA-targeted radiotracers: rationale, current state of the field, and a Call to Arms. J Nucl Med. 2018;59(6):871\u20137.","journal-title":"J Nucl Med"},{"issue":"9","key":"175_CR10","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1007\/s00259-015-3066-x","volume":"42","author":"M Sathekge","year":"2015","unstructured":"Sathekge M, Modiselle M, Vorster M, et al. (68) Ga-PSMA imaging of metastatic breast cancer. Eur J Nucl Med Mol Imaging. 2015;42(9):1482\u20133.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"7","key":"175_CR11","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s00259-014-2766-y","volume":"41","author":"E Demirci","year":"2014","unstructured":"Demirci E, Ocak M, Kabasakal L, et al. (68) Ga-PSMA PET\/CT imaging of metastatic clear cell renal cell carcinoma. Eur J Nucl Med Mol Imaging. 2014;41(7):1461\u20132.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"175_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s00259-014-2921-5","volume":"42","author":"J Schwenck","year":"2015","unstructured":"Schwenck J, Tabatabai G, Skardelly M, et al. In vivo visualization of prostate-specific membrane antigen in glioblastoma. Eur J Nucl Med Mol Imaging. 2015;42(1):170\u20131.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"175_CR13","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00259-015-3297-x","volume":"43","author":"A Sasikumar","year":"2016","unstructured":"Sasikumar A, Joy A, Nanabala R, Pillai MR, Thomas B, Vikraman KR. (68) Ga-PSMA PET\/CT imaging in primary hepatocellular carcinoma. Eur J Nucl Med Mol Imaging. 2016;43(4):795\u20136.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"175_CR14","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1007\/s00259-015-3065-y","volume":"42","author":"FA Verburg","year":"2015","unstructured":"Verburg FA, Krohn T, Heinzel A, Mottaghy FM, Behrendt FF. First evidence of PSMA expression in differentiated thyroid cancer using [(6)(8) Ga]PSMA-HBED-CC PET\/CT. Eur J Nucl Med Mol Imaging. 2015;42(10):1622\u20133.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"175_CR15","doi-asserted-by":"publisher","first-page":"e167","DOI":"10.1097\/RLU.0000000000001072","volume":"41","author":"YT Huang","year":"2016","unstructured":"Huang YT, Fong W, Thomas P. Rectal Carcinoma on 68Ga-PSMA PET\/CT. Clin Nucl Med. 2016;41(3):e167\u20138.","journal-title":"Clin Nucl Med"},{"issue":"5","key":"175_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1097\/RLU.0000000000001139","volume":"41","author":"D Shetty","year":"2016","unstructured":"Shetty D, Loh H, Bui C, Mansberg R, Stevanovic A. Elevated 68Ga prostate-specific membrane antigen activity in metastatic non-small cell lung Cancer. Clin Nucl Med. 2016;41(5):414\u20136.","journal-title":"Clin Nucl Med"},{"issue":"6","key":"175_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1097\/RLU.0000000000001169","volume":"41","author":"GL Kanthan","year":"2016","unstructured":"Kanthan GL, Coyle L, Kneebone A, Schembri GP, Hsiao E. Follicular lymphoma showing avid uptake on 68Ga PSMA-HBED-CC PET\/CT. Clin Nucl Med. 2016;41(6):500\u20131.","journal-title":"Clin Nucl Med"},{"issue":"1","key":"175_CR18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00259-015-3235-y","volume":"43","author":"C Rischpler","year":"2016","unstructured":"Rischpler C, Maurer T, Schwaiger M, Eiber M. Intense PSMA-expression using (68) Ga-PSMA PET\/CT in a paravertebral schwannoma mimicking prostate cancer metastasis. Eur J Nucl Med Mol Imaging. 2016;43(1):193\u20134.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"6","key":"175_CR19","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1097\/RLU.0000000000001192","volume":"41","author":"GL Kanthan","year":"2016","unstructured":"Kanthan GL, Hsiao E, Kneebone A, Eade T, Schembri GP. Desmoid tumor showing intense uptake on 68Ga PSMA-HBED-CC PET\/CT. Clin Nucl Med. 2016;41(6):508\u20139.","journal-title":"Clin Nucl Med"},{"issue":"1","key":"175_CR20","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00259-015-3236-x","volume":"43","author":"C Artigas","year":"2016","unstructured":"Artigas C, Alexiou J, Garcia C, et al. Paget bone disease demonstrated on (68) Ga-PSMA ligand PET\/CT. Eur J Nucl Med Mol Imaging. 2016;43(1):195\u20136.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"175_CR21","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/RLU.0000000000000827","volume":"40","author":"C Kobe","year":"2015","unstructured":"Kobe C, Maintz D, Fischer T, Drzezga A, Chang DH. Prostate-Specific Membrane Antigen PET\/CT in Splenic Sarcoidosis. Clin Nucl Med. 2015;40(11):897\u20138.","journal-title":"Clin Nucl Med"},{"issue":"10","key":"175_CR22","doi-asserted-by":"publisher","first-page":"e449","DOI":"10.1097\/RLU.0000000000001291","volume":"41","author":"B Noto","year":"2016","unstructured":"Noto B, Vrachimis A, Schafers M, Stegger L, Rahbar K. Subacute stroke mimicking cerebral metastasis in 68Ga-PSMA-HBED-CC PET\/CT. Clin Nucl Med. 2016;41(10):e449\u201351.","journal-title":"Clin Nucl Med"},{"issue":"7","key":"175_CR23","doi-asserted-by":"publisher","first-page":"e346","DOI":"10.1097\/RLU.0000000000001222","volume":"41","author":"P Gykiere","year":"2016","unstructured":"Gykiere P, Goethals L, Everaert H. Healing sacral fracture masquerading as metastatic bone disease on a 68Ga-PSMA PET\/CT. Clin Nucl Med. 2016;41(7):e346\u20137.","journal-title":"Clin Nucl Med"},{"issue":"3","key":"175_CR24","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s40336-018-0282-y","volume":"6","author":"Alessandro Lambertini","year":"2018","unstructured":"Lambertini A, Castellucci P, Farolfi A, et al. Pictorial essay: normal variants, lesions, and pitfalls in 68Ga-PSMA PET imaging of prostate cancer. Clin Transl Imaging. 2018;6(3):239-47.","journal-title":"Clinical and Translational Imaging"},{"issue":"2","key":"175_CR25","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00259-014-2915-3","volume":"42","author":"T Krohn","year":"2015","unstructured":"Krohn T, Verburg FA, Pufe T, et al. [(68) Ga]-PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practice. Eur J Nucl Med Mol Imaging. 2015;42(2):210\u20134.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"175_CR26","doi-asserted-by":"publisher","first-page":"668","DOI":"10.2967\/jnumed.115.154153","volume":"56","author":"M Eiber","year":"2015","unstructured":"Eiber M, Maurer T, Souvatzoglou M, et al. Evaluation of hybrid (68) Ga-PSMA ligand PET\/CT in 248 patients with biochemical recurrence after radical prostatectomy. J Nucl Med. 2015;56(5):668\u201374.","journal-title":"J Nucl Med"},{"issue":"6","key":"175_CR27","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.eururo.2016.06.021","volume":"70","author":"M Perera","year":"2016","unstructured":"Perera M, Papa N, Christidis D, et al. Sensitivity, specificity, and predictors of positive (68) Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate Cancer: a systematic review and meta-analysis. Eur Urol. 2016;70(6):926\u201337.","journal-title":"Eur Urol"},{"issue":"1","key":"175_CR28","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2967\/jnumed.117.197160","volume":"59","author":"PJ Roach","year":"2018","unstructured":"Roach PJ, Francis R, Emmett L, et al. The impact of (68) Ga-PSMA PET\/CT on management intent in prostate Cancer: results of an Australian prospective multicenter study. J Nucl Med. 2018;59(1):82\u20138.","journal-title":"J Nucl Med"},{"issue":"12","key":"175_CR29","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.2967\/jnumed.116.185033","volume":"58","author":"M Vinsensia","year":"2017","unstructured":"Vinsensia M, Chyoke PL. Hadaschik B, et al. (68) Ga-PSMA PET\/CT and volumetric morphology of PET-positive lymph nodes stratified by tumor differentiation of prostate Cancer. J Nucl Med. 2017;58(12):1949\u201355.","journal-title":"J Nucl Med"},{"issue":"1","key":"175_CR30","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2967\/jnumed.117.192625","volume":"59","author":"A Afaq","year":"2018","unstructured":"Afaq A, Alahmed S, Chen SH, et al. Impact of (68) Ga-prostate-specific membrane antigen PET\/CT on prostate Cancer management. J Nucl Med. 2018;59(1):89\u201392.","journal-title":"J Nucl Med"},{"issue":"3","key":"175_CR31","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2967\/jnumed.117.202945","volume":"59","author":"J Calais","year":"2018","unstructured":"Calais J, Fendler WP, Eiber M, Gartmann J, Chu FI, Nickols NG, et al. Impact of (68) Ga-PSMA-11 PET\/CT on the Management of Prostate Cancer Patients with biochemical recurrence. J Nucl Med. 2018;59(3):434\u201341.","journal-title":"J Nucl Med"},{"issue":"11","key":"175_CR32","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.2967\/jnumed.116.172627","volume":"57","author":"WP Fendler","year":"2016","unstructured":"Fendler WP, Schmidt DF, Wenter V, et al. 68Ga-PSMA PET\/CT detects the location and extent of primary prostate Cancer. J Nucl Med. 2016;57(11):1720\u20135.","journal-title":"J Nucl Med"},{"issue":"3","key":"175_CR33","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.eururo.2015.06.010","volume":"69","author":"L Budaus","year":"2016","unstructured":"Budaus L, Leyh-Bannurah SR, Salomon G, et al. Initial experience of (68) Ga-PSMA PET\/CT imaging in high-risk prostate Cancer patients prior to radical prostatectomy. Eur Urol. 2016;69(3):393\u20136.","journal-title":"Eur Urol"},{"issue":"11","key":"175_CR34","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1007\/s00259-017-3752-y","volume":"44","author":"C Obek","year":"2017","unstructured":"Obek C, Doganca T, Demirci E, et al. The accuracy of (68) Ga-PSMA PET\/CT in primary lymph node staging in high-risk prostate cancer. Eur J Nucl Med Mol Imaging. 2017;44(11):1806\u201312.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"175_CR35","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12967-017-1333-2","volume":"15","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Zang S, Zhang C, et al. Comparison of (68) Ga-PSMA-11 PET-CT with mpMRI for preoperative lymph node staging in patients with intermediate to high-risk prostate cancer. J Transl Med. 2017;15(1):230.","journal-title":"J Transl Med"},{"key":"175_CR36","doi-asserted-by":"crossref","unstructured":"Zacho HD, Nielsen JB, Haberkorn U, Stenholt L, Petersen LJ. (68) Ga-PSMA PET\/CT for the detection of bone metastases in prostate cancer: a systematic review of the published literature. Clin Physiol Funct Imaging. 2018;38(6):911-22.","DOI":"10.1111\/cpf.12480"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-018-0175-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40644-018-0175-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-018-0175-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T05:52:25Z","timestamp":1572587545000},"score":1,"resource":{"primary":{"URL":"https:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-018-0175-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["175"],"URL":"https:\/\/doi.org\/10.1186\/s40644-018-0175-3","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,1]]},"assertion":[{"value":"30 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval was obtained by the local institutional review board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"39"}}